IL17F
Basic information
Region (hg38): 6:52236681-52245689
Links
Phenotypes
GenCC
Source:
- chronic mucocutaneous candidiasis (Supportive), mode of inheritance: AD
- candidiasis, familial, 6 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Candidiasis, familial, 6 | AD | Allergy/Immunology/Infectious | Individuals may manifest with chronic cutaneous candidiasis, and awareness may allow early detection and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious | 21350122 |
ClinVar
This is a list of variants' phenotypes submitted to
- Candidiasis,_familial,_6 (140 variants)
- not_specified (24 variants)
- not_provided (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL17F gene is commonly pathogenic or not. These statistics are base on transcript: NM_000052872.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 38 | 40 | ||||
| missense | 82 | 87 | ||||
| nonsense | 1 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 3 | |||||
| Total | 0 | 0 | 86 | 46 | 2 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| IL17F | protein_coding | protein_coding | ENST00000336123 | 3 | 7857 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0392 | 0.849 | 125346 | 1 | 390 | 125737 | 0.00156 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.160 | 103 | 98.5 | 1.05 | 0.00000612 | 1057 |
| Missense in Polyphen | 33 | 29.148 | 1.1321 | 318 | ||
| Synonymous | -2.00 | 56 | 39.9 | 1.40 | 0.00000247 | 334 |
| Loss of Function | 1.29 | 3 | 6.55 | 0.458 | 3.78e-7 | 67 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00174 | 0.00174 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0138 | 0.0139 |
| Finnish | 0.000509 | 0.000508 |
| European (Non-Finnish) | 0.000238 | 0.000237 |
| Middle Eastern | 0.0138 | 0.0139 |
| South Asian | 0.00147 | 0.00144 |
| Other | 0.000978 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Ligand for IL17RA and IL17RC (PubMed:17911633). The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC (PubMed:18684971). Involved in stimulating the production of other cytokines such as IL6, IL8 and CSF2, and in regulation of cartilage matrix turnover (PubMed:11591732, PubMed:11591768, PubMed:11574464). Also involved in stimulating the proliferation of peripheral blood mononuclear cells and T-cells and in inhibition of angiogenesis (PubMed:11591732). Plays a role in the induction of neutrophilia in the lungs and in the exacerbation of antigen-induced pulmonary allergic inflammation (By similarity). {ECO:0000250|UniProtKB:Q7TNI7, ECO:0000269|PubMed:11574464, ECO:0000269|PubMed:11591732, ECO:0000269|PubMed:11591768, ECO:0000269|PubMed:17911633, ECO:0000269|PubMed:18684971}.;
- Pathway
- Inflammatory bowel disease (IBD) - Homo sapiens (human);Th17 cell differentiation - Homo sapiens (human);IL-17 signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);IL17 signaling pathway;Interleukin-4 and 13 signaling;IL23-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.384
Intolerance Scores
- loftool
- 0.587
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.23
Haploinsufficiency Scores
- pHI
- 0.0767
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0569
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il17f
- Phenotype
- growth/size/body region phenotype; craniofacial phenotype; skeleton phenotype; respiratory system phenotype; hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; immune system phenotype;
Gene ontology
- Biological process
- inflammatory response;regulation of signaling receptor activity;negative regulation of angiogenesis;regulation of transforming growth factor beta receptor signaling pathway;cytokine-mediated signaling pathway;cytokine biosynthetic process;lymphotoxin A biosynthetic process;regulation of interleukin-2 biosynthetic process;regulation of interleukin-6 biosynthetic process;regulation of interleukin-8 biosynthetic process;regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;positive regulation of transcription by RNA polymerase II;cartilage development;interleukin-17-mediated signaling pathway;positive regulation of cytokine production involved in inflammatory response;positive regulation of interleukin-6 secretion
- Cellular component
- extracellular region;extracellular space
- Molecular function
- cytokine activity;cytokine receptor binding;protein binding;cytokine binding;protein homodimerization activity